Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs ALEMBIC PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA ALEMBIC PHARMA ASTRAZENECA PHARMA/
ALEMBIC PHARMA
 
P/E (TTM) x 95.5 32.2 296.3% View Chart
P/BV x 22.7 4.4 513.6% View Chart
Dividend Yield % 0.3 0.8 36.9%  

Financials

 ASTRAZENECA PHARMA   ALEMBIC PHARMA
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-23
ALEMBIC PHARMA
Mar-23
ASTRAZENECA PHARMA/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs3,620792 456.9%   
Low Rs2,438463 526.2%   
Sales per share (Unadj.) Rs401.2287.6 139.5%  
Earnings per share (Unadj.) Rs39.717.4 228.3%  
Cash flow per share (Unadj.) Rs46.231.4 147.1%  
Dividends per share (Unadj.) Rs16.008.00 200.0%  
Avg Dividend yield %0.51.3 41.5%  
Book value per share (Unadj.) Rs234.4222.3 105.4%  
Shares outstanding (eoy) m25.00196.56 12.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.52.2 345.8%   
Avg P/E ratio x76.336.1 211.3%  
P/CF ratio (eoy) x65.520.0 327.9%  
Price / Book Value ratio x12.92.8 457.5%  
Dividend payout %40.346.0 87.6%   
Avg Mkt Cap Rs m75,718123,402 61.4%   
No. of employees `000NANA-   
Total wages/salary Rs m2,59111,691 22.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,03056,526 17.7%  
Other income Rs m26130 858.6%   
Total revenues Rs m10,29156,557 18.2%   
Gross profit Rs m1,2496,772 18.4%  
Depreciation Rs m1632,754 5.9%   
Interest Rs m6502 1.3%   
Profit before tax Rs m1,3413,546 37.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m348126 276.1%   
Profit after tax Rs m9933,420 29.0%  
Gross profit margin %12.512.0 103.9%  
Effective tax rate %26.03.6 730.0%   
Net profit margin %9.96.1 163.6%  
BALANCE SHEET DATA
Current assets Rs m9,35929,139 32.1%   
Current liabilities Rs m4,84416,408 29.5%   
Net working cap to sales %45.022.5 199.9%  
Current ratio x1.91.8 108.8%  
Inventory Days Days4910 510.6%  
Debtors Days Days397 579.1%  
Net fixed assets Rs m2,06131,498 6.5%   
Share capital Rs m50393 12.7%   
"Free" reserves Rs m5,81143,312 13.4%   
Net worth Rs m5,86143,705 13.4%   
Long term debt Rs m00-   
Total assets Rs m11,42160,637 18.8%  
Interest coverage x213.98.1 2,650.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.9 94.2%   
Return on assets %8.76.5 135.3%  
Return on equity %16.97.8 216.5%  
Return on capital %23.09.3 248.2%  
Exports to sales %046.4 0.0%   
Imports to sales %37.412.1 308.5%   
Exports (fob) Rs mNA26,210 0.0%   
Imports (cif) Rs m3,7476,846 54.7%   
Fx inflow Rs m61226,210 2.3%   
Fx outflow Rs m3,7476,846 54.7%   
Net fx Rs m-3,13519,364 -16.2%   
CASH FLOW
From Operations Rs m5837,240 8.1%  
From Investments Rs m181-4,476 -4.0%  
From Financial Activity Rs m-245-2,620 9.3%  
Net Cashflow Rs m519144 360.8%  

Share Holding

Indian Promoters % 0.0 69.1 -  
Foreign collaborators % 75.0 0.5 14,705.9%  
Indian inst/Mut Fund % 5.4 19.0 28.5%  
FIIs % 2.7 4.5 58.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 30.4 82.3%  
Shareholders   29,032 85,212 34.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ASTRAZENECA PHARMA vs ALEMBIC PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs ALEMBIC PHARMA Share Price Performance

Period ASTRAZENECA PHARMA ALEMBIC PHARMA S&P BSE HEALTHCARE
1-Day 0.01% -0.15% 1.18%
1-Month -3.61% -4.30% -0.75%
1-Year 59.20% 105.43% 61.82%
3-Year CAGR 20.50% 0.89% 18.16%
5-Year CAGR 22.18% 13.56% 19.79%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the ALEMBIC PHARMA share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of ALEMBIC PHARMA the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of ALEMBIC PHARMA.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 16.0 per share. This amounted to a Dividend Payout ratio of 40.3%.

ALEMBIC PHARMA paid Rs 8.0, and its dividend payout ratio stood at 46.0%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of ALEMBIC PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.